Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $233,920 - $263,449
-1,700 Reduced 68.0%
800 $123,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $333,975 - $386,625
2,500 New
2,500 $372,000
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $361,525 - $416,350
2,500 New
2,500 $398,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.